Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells

  • Post author:
  • Post published:October 6, 2026
  • Post category:

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that is rapidly fatal within months if untreated. Even with aggressive treatment, including chemotherapy and bone marrow…

Continue ReadingDevelopment of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells

Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors

  • Post author:
  • Post published:October 6, 2026
  • Post category:

Cancer is a major cause of human death worldwide. The vast majority of cancer patients suffer from solid tumors whose growth destroys vital organs. We propose to develop novel therapeutic…

Continue ReadingTherapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors

ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS

  • Post author:
  • Post published:October 6, 2026
  • Post category:

Some years ago it was discovered that patients homozygous for a natural mutation (the Δ32 mutation) in the CCR5 gene are generally resistant to HIV infection by blocking virus entry…

Continue ReadingZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS

Stem cell based treatment strategy for Age-related Macular Degeneration (AMD)

  • Post author:
  • Post published:October 6, 2026
  • Post category:

Retinal degeneration represents a group of blinding diseases that are increasingly impacting the health and well being of Californians. It is estimated that by 2020, over 450,000 Californians will suffer…

Continue ReadingStem cell based treatment strategy for Age-related Macular Degeneration (AMD)

Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)

  • Post author:
  • Post published:October 6, 2026
  • Post category:

Leukemias are cancers of the blood forming cells that afflict both children and adults. Many drugs have been developed to treat leukemias and related diseases. These drugs are often effective…

Continue ReadingDevelopment of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)

Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes

  • Post author:
  • Post published:October 5, 2026
  • Post category:

Continue ReadingHypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes

Regenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes.

  • Post author:
  • Post published:October 5, 2026
  • Post category:

Continue ReadingRegenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes.

Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis

  • Post author:
  • Post published:October 5, 2026
  • Post category:

Continue ReadingStem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis

A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events

  • Post author:
  • Post published:October 5, 2026
  • Post category:

Continue ReadingA First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events

Gene Therapy for Alpha-1 Anti-Trypsin Deficiency

  • Post author:
  • Post published:October 5, 2026
  • Post category:

Continue ReadingGene Therapy for Alpha-1 Anti-Trypsin Deficiency
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 60
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us